WSC
JUNO

Wellington Shields & Co’s Juno Therapeutics, Inc. JUNO Stock Holding History

Wellington Shields & Co’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,200
Closed -$283K – 156
2017
Q4 		$283K Buy
6,200
+1,700
+38% +$84.8K 0.15% 120
2017
Q3 		$202K Buy
+4,500
New +$153K 0.07% 134

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Wellington Shields & Co's JUNO Position: Q1 2018 in Review

Wellington Shields & Co sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 6,200 shares — an estimated $283K sold.

Wellington Shields & Co first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $283K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Wellington Shields & Co reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Wellington Shields & Co sold 6,200 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $283K.
  • Wellington Shields & Co first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • Wellington Shields & Co's Juno Therapeutics, Inc. position peaked at $283K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Wellington Shields & Co's 13F filing for Q1 2018, filed 3 May 2018.